SCHEMBL15325943

SCHEMBL15325943

CCOC(=O)C1(C(=O)OCC)C[C@H]1CC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 3/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
ALOX15 P16050 2/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
F10 P00742 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11179315 1.00 ALDH1A1 (0.37) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL15325061 0.90 MAPK1 (0.36) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL7392445 0.90 MAPK1 (0.36) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL15325068 0.90 LMNA (0.37) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL10953253 0.90 LMNA (0.37) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL7392441 0.90 MAPK1 (0.36) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL7392443 0.90 MAPK1 (0.36) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL12037366 0.90 LMNA (0.37) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL15325080 0.89 MAPK1 (0.35) ALDH1A1POLBLMNAHSD17B10MAPK1
SCHEMBL30706721 0.86 POLB (0.36) ALDH1A1POLBLMNAHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120818-B2 Process and intermediates for preparing macrolactams MERCK SHARP & DOHME CORP. (US) 2015-09-01 US disclosed
US-20130274463-A1 PROCESS AND INTERMEDIATES FOR PREPARING MACROLACTAMS MERCK SHARP & DOHME CORP. 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274463-A1 PROCESS AND INTERMEDIATES FOR PREPARING MACROLACTAMS EMG1, MRPS18B, MLN ALDH1A1 3301/4885POLB 2182/4885LMNA 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.